Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
22.86
-0.26 (-1.12%)
At close: Jul 24, 2026, 4:00 PM EDT
22.95
+0.09 (0.39%)
Pre-market: Jul 27, 2026, 7:01 AM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.64 billion as of July 27, 2026. Its market cap has increased by 64.34% in one year.
Market Cap
1.64B
Enterprise Value
1.25B
1-Year Change
64.34%
Ranking
Category
Stock Price
$22.86
ChartMarket Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.64B, an increase of 396.80%. That is a compound annual growth rate of 18.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.67B | -15.28% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 1.75B |
| Generate Biomedicines | 1.72B |
| Ascentage Pharma Group International | 1.66B |
| MapLight Therapeutics | 1.66B |
| Sarepta Therapeutics | 1.66B |
| AbCellera Biologics | 1.62B |
| AnaptysBio | 1.60B |
| Innoviva | 1.58B |